JPRN-UMIN000015438招募中未知
Clinical trial of combined therapy using robot-assisted arm training(AT) with transcranial direct current stimulation(tDCS) or transcranial magnetic stimulation(TMS) for impairment of the upper limb in chronic post-stroke patients. - Clinical trial of combined therapy using robot-assisted arm training(AT) with transcranial direct current stimulation(tDCS) or transcranial magnetic stimulation(TMS) for impairment of the upper limb in chronic post-stroke patients.
niversity of Environmental Health Department of Rehabiliration medicine, School of Medicine0 个研究点目标入组 60 人开始时间: 2014年10月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Previous stroke Preceding epilepsy Severe cognitive impairments Serious cardiac or orthopaedic problems Metallic implants within the brain
研究者
相似试验
招募中
2 期
Effects of Robot-assisted Therapy Combining with Task-oriented Training on Paretic Upper Extremity Functions in Clients with Sub-acute StrokeThe first stroke with hemiparesis for 3-6 months (sub-acute stage), and had Brunnstrom stages of recovery II - V.Robot-assistive therapy, Task-oriented therapy, Occupational Therapy, Sub-acute Stroke, Upper Extremity RehabilitationTCTR20240315001Faculty of Associated Medical Sciences, Chiang Mai University20
Unknown
2 期
Effects of Robot-assisted Therapy Combining with Task-oriented Training on Paretic Upper Extremity Functions in Clients with Sub-acute StrokeThe first stroke with hemiparesis for 3-6 months (sub-acute stage), and had Brunnstrom stages of recovery II - V.Robot-assisted therapy, Task-oriented therapy, Occupational Therapy, Sub-acute Stroke, Upper Extremity RehabilitationTCTR20220719006Faculty of Associated Medical Sciences, Chiang Mai University20
已完成
不适用
Clinical trial on the efficacy and safety of robot assisted laparoscopic partial nephrectomy using Davinci surgical systemrenal tumorJPRN-UMIN000013785the department of urology, kansai medical university30
进行中（未招募）
不适用
Pilot study - sequential combination therapy using selective immunoglobulin apheresis and omalizumab in patients with severe atopic dermatitis and elevated total IgE levelsPatients with severe Atopic dermatitis and total IgE-level > 700 IU/ml (potentially associated with bronchial asthma and/or allergic rhinitis)MedDRA version: 12.0Level: LLTClassification code 10002198Term: Anaphylactic reactionMedDRA version: 12.0Level: LLTClassification code 10040400Term: Serum sicknessMedDRA version: 12.0Level: LLTClassification code 10043554Term: ThrombocytopeniaMedDRA version: 12.0Level: LLTClassification code 10019211Term: HeadacheMedDRA version: 12.0Level: LLTClassification code 10028810Term: NasopharyngitisMedDRA version: 12.0Level: LLTClassification code 10040753Term: SinusitisMedDRA version: 12.0Level: LLTClassification code 10022000Term: InfluenzaMedDRA version: 12.0Level: LLTClassification code 10006451Term: BronchitisMedDRA version: 12.0Level: LLTClassification code 10017888Term: GastroenteritisMedDRA version: 12.0Level: LLTClassification code 10034835Term: PharyngitisMedDRA version: 12.0Level: LLTClassification code 10047461Term: Viral infectionMedDRA version: 12.0Level: LLTClassification code 10034844Term: Pharyngolaryngeal painMedDRA version: 12.0Level: LLTClassification code 10011224Term: CoughMedDRA version: 12.0Level: LLTClassification code 10039083Term: RhinitisMedDRA version: 12.0Level: LLTClassification code 10028735Term: Nasal congestionMedDRA version: 12.0Level: LLTClassification code 10039085Term: Rhinitis allergicMedDRA version: 12.0Level: LLTClassification code 10012727Term: DiarrheaMedDRA version: 12.0Level: LLTClassification code 10028813Term: NauseaMedDRA version: 12.0Level: LLTClassification code 10013946Term: DyspepsiaMedDRA version: 12.0Level: LLTClassification code 10003988Term: Back painMedDRA version: 12.0Level: LLTClassification code 10003239Term: ArthralgiaMedDRA version: 12.0Level: LLTClassification code 10028411Term:EUCTR2009-014582-51-DEFaculty of Medicine, Technische Universität München
尚未招募
不适用
Phase I and II trial of combination therapy using nab-Paclitaxel+Pertuzumab+Trastuzumab for HER2 positive metastatic breast cancermetastatic breast cancerJPRN-UMIN000035869The University of Tokushima Graduate School, Depertment of Thoracic, Endocrine surgery and Oncology, Institute of Health Bioscience30